Peiran Wei , Yan Xu , Huikang Zhang , Qingqiang Yao , Liming Wang
{"title":"Evaluation of outcomes of discectomy with a dynamic neutralization system in treatment of lumbar disk herniation","authors":"Peiran Wei , Yan Xu , Huikang Zhang , Qingqiang Yao , Liming Wang","doi":"10.1016/j.neucie.2022.11.020","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The study aimed to explore the clinical outcomes of discectomy with dynamic neutralization system (Dynesys) for single-segmental lumbar disk herniation (LDH) versus simple discectomy.</p></div><div><h3>Methods</h3><p>The eligible patients with single-segmental LDH were randomly divided into the discectomy with Dynesys group (group A) and the simple discectomy group (group B). The Oswestry disability index (ODI), visual analog score (VAS), radiological results of intervertebral height and range of motion (ROM) of the treated segment were evaluated pre- and post-operatively in both groups. Operation duration and blood loss were recorded. Complications, reoperation, and mortality were also assessed. All patients received a 2-year follow-up.</p></div><div><h3>Results</h3><p>123 (96.1%) participants completed the follow-up. The operation duration and blood loss of group B were significantly lower than those of group A (<em>p</em> <!--><<!--> <span>0.05). After operation, ODI and VAS were improved significantly in both groups, and there was no significant difference between the two groups immediately after surgery. But a rising trend was found in ODI and VAS of group B, especially after the 1-year follow-up (</span><em>p</em> <!--><<!--> <!-->0.05). X-rays showed a continuing loss of intervertebral height of the treated segment in group B, while it was preserved in group A (<em>p</em> <!--><<!--> <!-->0.05). ROM of the treated segment was also maintained stable in group A.</p></div><div><h3>Conclusion</h3><p>Discectomy with Dynesys is safe and effective for LDH treatment.</p></div>","PeriodicalId":74273,"journal":{"name":"Neurocirugia (English Edition)","volume":"34 4","pages":"Pages 161-167"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurocirugia (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2529849622000958","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
The study aimed to explore the clinical outcomes of discectomy with dynamic neutralization system (Dynesys) for single-segmental lumbar disk herniation (LDH) versus simple discectomy.
Methods
The eligible patients with single-segmental LDH were randomly divided into the discectomy with Dynesys group (group A) and the simple discectomy group (group B). The Oswestry disability index (ODI), visual analog score (VAS), radiological results of intervertebral height and range of motion (ROM) of the treated segment were evaluated pre- and post-operatively in both groups. Operation duration and blood loss were recorded. Complications, reoperation, and mortality were also assessed. All patients received a 2-year follow-up.
Results
123 (96.1%) participants completed the follow-up. The operation duration and blood loss of group B were significantly lower than those of group A (p < 0.05). After operation, ODI and VAS were improved significantly in both groups, and there was no significant difference between the two groups immediately after surgery. But a rising trend was found in ODI and VAS of group B, especially after the 1-year follow-up (p < 0.05). X-rays showed a continuing loss of intervertebral height of the treated segment in group B, while it was preserved in group A (p < 0.05). ROM of the treated segment was also maintained stable in group A.
Conclusion
Discectomy with Dynesys is safe and effective for LDH treatment.